Kura Oncology, Inc. - Common Stock (KURA)

CUSIP: 50127T109

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common Stock
Shares outstanding
87,054,674
Total 13F shares
19,535,236
Share change
+31,606
Total reported value
$298,877,651
Price per share
$15.30
Number of holders
73
Value change
+$581,471
Number of buys
39
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of KURA - Kura Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
EcoR1 Capital, LLC
13F
Company
4.3%
3,766,852
$56,314,000 30 Sep 2017
13F
FMR LLC
13F
Company
3%
2,586,919
$38,674,000 30 Sep 2017
13F
PFM Health Sciences, LP
13F
Company
2.8%
2,411,552
$36,053,000 30 Sep 2017
13F
GREAT POINT PARTNERS LLC
13F
Company
2%
1,750,887
$26,176,000 30 Sep 2017
13F
BVF INC/IL
13F
Company
1.6%
1,353,846
$20,240,000 30 Sep 2017
13F
BlackRock Finance, Inc.
13F
Company
1.2%
1,022,521
$15,287,000 30 Sep 2017
13F
VANGUARD GROUP INC
13F
Company
1.1%
984,776
$14,723,000 30 Sep 2017
13F
Boxer Capital, LLC
13F
Company
0.97%
844,789
$12,630,000 30 Sep 2017
13F
S.c.a. Candriam
13F
Individual
0.62%
540,000
$8,073,000 30 Sep 2017
13F
BANK OF MONTREAL /CAN/
13F
Company
0.46%
402,434
$6,018,000 30 Sep 2017
13F
Sio Capital Management, LLC
13F
Company
0.32%
275,731
$4,122,000 30 Sep 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.31%
266,400
$3,983,000 30 Sep 2017
13F
NEXTHERA CAPITAL LP
13F
Company
0.3%
258,516
$3,865,000 30 Sep 2017
13F
STATE STREET CORP
13F
Company
0.28%
241,878
$3,612,000 30 Sep 2017
13F
Minerva Advisors LLC
13F
Company
0.26%
228,221
$3,401,000 30 Sep 2017
13F
CLOUGH CAPITAL PARTNERS L P
13F
Company
0.26%
224,861
$3,362,000 30 Sep 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.26%
223,916
$3,348,000 30 Sep 2017
13F
NORTHERN TRUST CORP
13F
Company
0.24%
209,879
$3,137,000 30 Sep 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.23%
198,990
$2,974,000 30 Sep 2017
13F
Informed Momentum Co LLC
13F
Company
0.22%
192,924
$2,884,000 30 Sep 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.19%
163,659
$2,446,000 30 Sep 2017
13F
ALETHEA CAPITAL MANAGEMENT, LLC
13F
Company
0.13%
111,673
$1,670,000 30 Sep 2017
13F
DAFNA Capital Management LLC
13F
Company
0.12%
105,859
$1,583,000 30 Sep 2017
13F
Artal Group S.A.
13F
Company
0.11%
100,000
$1,495,000 30 Sep 2017
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.11%
92,200
$1,378,000 30 Sep 2017
13F
Iguana Healthcare Management, LLC
13F
Company
0.1%
90,000
$1,346,000 30 Sep 2017
13F
Virtu Financial LLC
13F
Company
0.08%
68,658
$1,026,000 30 Sep 2017
13F
ALTRINSIC GLOBAL ADVISORS LLC
13F
Company
0.07%
60,000
$897,000 30 Sep 2017
13F
Bank of New York Mellon Corp
13F
Company
0.07%
59,281
$886,000 30 Sep 2017
13F
JPMORGAN CHASE & CO
13F
Company
0.06%
55,471
$802,000 30 Sep 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.05%
46,650
$697,000 30 Sep 2017
13F
Nationwide Fund Advisors
13F
Company
0.05%
42,981
$643,000 30 Sep 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.05%
39,200
$587,000 30 Sep 2017
13F
MORGAN STANLEY
13F
Company
0.04%
37,756
$565,000 30 Sep 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.04%
31,500
$471,000 30 Sep 2017
13F
PILLAR PACIFIC CAPITAL MANAGEMENT LLC
13F
Company
0.04%
30,500
$456,000 30 Sep 2017
13F
J.P. Morgan Private Wealth Advisors LLC
13F
Company
0.03%
29,500
$441,000 30 Sep 2017
13F
Partner Investment Management, L.P.
13F
Company
0.03%
25,717
$384,000 30 Sep 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.03%
24,816
$371,000 30 Sep 2017
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.03%
23,500
$351,000 30 Sep 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.02%
19,632
$293,000 30 Sep 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
17,300
$259,000 30 Sep 2017
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.02%
16,634
$249,000 30 Sep 2017
13F
UBS Group AG
13F
Company
0.02%
15,204
$227,000 30 Sep 2017
13F
RHUMBLINE ADVISERS
13F
Company
0.02%
14,845
$222,000 30 Sep 2017
13F
METROPOLITAN LIFE INSURANCE CO/NY
13F
Company
0.02%
14,568
$218,000 30 Sep 2017
13F
ELLINGTON MANAGEMENT GROUP LLC
13F
Company
0.02%
14,200
$212,000 30 Sep 2017
13F
CREDIT SUISSE AG/
13F
Company
0.01%
12,761
$190,000 30 Sep 2017
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.01%
11,000
$164,000 30 Sep 2017
13F
Parallax Volatility Advisers, L.P.
13F
Company
0.01%
10,000
$150,000 30 Sep 2017
13F

Institutional Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q4 2017

As of 31 Dec 2017, Kura Oncology, Inc. - Common Stock (KURA) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,535,236 shares. The largest 10 holders included EcoR1 Capital, LLC, GREAT POINT PARTNERS LLC, FMR LLC, Partner Fund Management, L.P., BlackRock Inc., BVF INC/IL, Vanguard Group Inc, Boxer Capital, LLC, Candriam Luxembourg S.C.A., and NEXTHERA CAPITAL LP. This page lists 73 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders
64
Q4 2017 holders
73
Holder diff
9
Investor Q3 2017 Shares Q4 2017 Shares Share Diff Share Chg % Q3 2017 Value $ Q4 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.